Medicamen Biotech Ltd Q4 FY2023-2024 Results: Summary

Revenue
₹47.89Cr
Net Profits
₹2.13Cr
Net Profit Margins
4.45%

Highlights

Revenue:

Medicamen Biotech Ltd’s revenue jumped 22.76% since last year same period to ₹47.89Cr in the Q4 2023-2024. On a quarterly growth basis, Medicamen Biotech Ltd has generated 1.18% jump in its revenue since last 3-months.

Net Profits:

Medicamen Biotech Ltd’s net profit fell -45.24% since last year same period to ₹2.13Cr in the Q4 2023-2024. On a quarterly growth basis, Medicamen Biotech Ltd has generated -11.25% fall in its net profits since last 3-months.

Net Profit Margins:

Medicamen Biotech Ltd’s net profit margin fell -55.4% since last year same period to 4.45% in the Q4 2023-2024. On a quarterly growth basis, Medicamen Biotech Ltd has generated -12.29% fall in its net profit margins since last 3-months.

FAQs

The revenue for Medicamen Biotech Ltd in the Q4 results 2023 was ₹47.89Cr.

The net profit for Medicamen Biotech Ltd in the Q4 results 2023 was ₹2.13Cr.

The net profit margin for Medicamen Biotech Ltd in the Q4 results 2023 was 4.45%.

The revenue for Medicamen Biotech Ltd in the Q4 results 2022 was ₹39.01Cr.

The net profit for Medicamen Biotech Ltd in the Q4 results 2022 was ₹3.89Cr.

The net profit margin for Medicamen Biotech Ltd in the Q4 results 2022 was 9.97%.